Médica Sur, S.A.B. de C.V.

Mexico Stock Exchange MEDICAB.MX

Médica Sur, S.A.B. de C.V. Gross Profit for the year ending December 31, 2023: USD 85.94 M

Médica Sur, S.A.B. de C.V. Gross Profit is USD 85.94 M for the year ending December 31, 2023, a 22.60% change year over year. Gross profit is the difference between revenue and the cost of revenue, representing the profit earned from core business operations.
  • Médica Sur, S.A.B. de C.V. Gross Profit for the year ending December 31, 2022 was USD 70.10 M, a -6.22% change year over year.
  • Médica Sur, S.A.B. de C.V. Gross Profit for the year ending December 31, 2021 was USD 74.75 M, a -13.67% change year over year.
  • Médica Sur, S.A.B. de C.V. Gross Profit for the year ending December 31, 2020 was USD 86.58 M, a 50.09% change year over year.
  • Médica Sur, S.A.B. de C.V. Gross Profit for the year ending December 31, 2019 was USD 57.69 M, a 1.11% change year over year.
Key data
Date Gross Profit Operating Income EBIT EBITDA
Market news
Mexico Stock Exchange: MEDICAB.MX

Médica Sur, S.A.B. de C.V.

CEO Dr. Carlos Arellano Quintana
IPO Date Jan. 4, 2000
Location Mexico
Headquarters Puente de Piedra 150
Employees 2,146
Sector Health Care
Industries
Hospitals & Clinics Medical Instruments Pharmaceuticals
Description

Médica Sur, S.A.B. de C.V. operates as a healthcare institution in Mexico. The company offers bypass and gastric banding, cholecystectomy, inguinal hernia repair, liposculpture, breast cosmetic, stereotactic radio, hip arthroplasty, knee arthroscopy, shoulder arthroscopy, spine, lithiasis, radical prostatectomy, and prostate surgeries. It also provides radiotherapy, imaging, and checkup services, as well as medical insurance services. The company was incorporated in 1966 and is based in Mexico City, Mexico. Médica Sur, S.A.B. de C.V. is a subsidiary of Neuco, SA de CV.

StockViz Staff

January 15, 2025

Any question? Send us an email